tiprankstipranks
Sagimet Biosciences, Inc. Class A (SGMT)
NASDAQ:SGMT
US Market
SGMT
Sagimet Biosciences, Inc. Class A
RESEARCH TOOLSreports
Want to see SGMT full AI Analyst Report?

Sagimet Biosciences, Inc. Class A (SGMT) Stock News & Sentiment

1,720 Followers
Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
2d ago
DE
HD
SGMT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SGMT Upcoming Earnings Report: What to Expect?
2d ago
SGMT
Sagimet Maintained at Buy as Strong Cash Runway and Advancing Acne Franchise Support Unchanged $28 Price Target
Premium
Ratings
Sagimet Maintained at Buy as Strong Cash Runway and Advancing Acne Franchise Support Unchanged $28 Price Target
7d ago
SGMT
Sagimet Therapeutics: Buy Rating Reiterated on Denifanstat’s First-Line Acne Potential; $28 Price Target Unchanged
Premium
Ratings
Sagimet Therapeutics: Buy Rating Reiterated on Denifanstat’s First-Line Acne Potential; $28 Price Target Unchanged
19d ago
SGMT
3 Penny Stocks to Watch Now, 4/28/26
Premium
Market News
3 Penny Stocks to Watch Now, 4/28/26
22d ago
HTCO
SGMT
Sagimet Biosciences Announces Major Equity Offering for Pipeline
Premium
Company Announcements
Sagimet Biosciences Announces Major Equity Offering for Pipeline
22d ago
8K
SGMT
Sagimet Updates Investor Presentation After Key Clinical Milestones
Premium
Company Announcements
Sagimet Updates Investor Presentation After Key Clinical Milestones
23d ago
8K
SGMT
More SGMT News >

SGMT News on the Web

Sagimet Biosciences price target lowered to $12 from $35 at Citizens
TipRanks News
Neutral
Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
TipRanks News
Neutral
SGMT Upcoming Earnings Report: What to Expect?
TipRanks News
Neutral
Sagimet Biosciences, Inc. Class A (SGMT) Receives a Rating Update from a Top Analyst
TipRanks News
Bullish
Sagimet Biosciences price target lowered to $28 from $37 at Clear Street
TipRanks News
Neutral
Sagimet Maintained at Buy as Strong Cash Runway and Advancing Acne Franchise Support Unchanged $28 Price Target
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: Coya Therapeutics, Inc. (COYA), Sagimet Biosciences, Inc. Class A (SGMT)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
SGMT
Sector Average
Media Buzz
This Week4 articles
Weekly Average6.75 articles
News Sentiment
This Week99%
Sector Average77%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SGMT’s Media Buzz Sentiment?
4 articles about SGMT were published this week. In an average week, 6.75 articles are published.
    What is SGMT’s weekly average amount of articles?
    In an average week, 6.75 articles about SGMT are published.
      What is SGMT’s News Sentiment?
      99% of articles about SGMT were positive this week, compared to its sector average of 77%.
        Healthcare Stocks that are Trending in the News
        DOCSDoximity
        AVAHAveanna Healthcare Holdings
        GOSSGossamer Bio
        CGENCompugen
        RLAYRelay Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week